872 results on '"Rosenblat, Joshua D"'
Search Results
202. Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials
203. Clinician Administered Dissociative States Scale–6-Item
204. McIntyre and Rosenblat Rapid Response Scale
205. Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation
206. Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence
207. Bipolar disorders
208. The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases?
209. Is ketamine a litmus test for capacity in assisted dying with depression?
210. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
211. Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis
212. Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials
213. Deficits of social cognition in bipolar disorder: Systematic review and meta‐analysis.
214. Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?
215. Trace elements differences in the depression sensitive and resilient rat models
216. Synergistic effect of social media use and psychological distress on depression in China during the COVID ‐19 epidemic
217. The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder
218. The Mental Health Effects of COVID-19 on Health Care Providers in China
219. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
220. Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
221. Correction
222. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
223. Leptin, obesity, and response to ketamine
224. Using early changes in cold cognition to predict response to vortioxetine in major depressive disorder
225. Drs Rosenblat and McIntyre Reply
226. Depression in the medically ill
227. Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence
228. The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset
229. Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation
230. supplemental_materials – Supplemental material for Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial
231. Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.
232. Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
233. The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases?
234. Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression.
235. Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.
236. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial
237. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression
238. Stress, epigenetics and depression: A systematic review
239. Letter to the Editor: Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed?
240. Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
241. The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders
242. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review
243. Consumer Warning for Genetic Tests Claiming to Predict Response to Medications: Implications for Psychiatry
244. Oral Ketamine for Depression
245. Ecological Momentary Assessment of Depressive Symptoms Using the mind.me Application: A Validation Study (Preprint)
246. The long-term effect of bariatric surgery on depression and anxiety
247. Parental characteristics and the risk of schizophrenia in a Chinese population: a case-control study
248. Targeting the immune system in the treatment of bipolar disorder
249. Expert Consensus on Screening and Assessment of Cognition in Psychiatry
250. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.